At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the ongoing hostile recessionary environment.
1. Spongetech Delivery Systems, Inc. (+ 948% as of April/1/09) ( Link to article )
2. Mesa Air Group, Inc. (+75% as of April/24/09) ( Link to article )
3. Hemispherx Biopharma, Inc. (+ 52% as of May/8/09) ( Link to article )
4. Access Pharmaceuticals (+57% as of June/10/09) ( Link to article )
5. Nephros, Inc. (+58.4% as of June/17/09) ( Link to article )
6. Bioelectronics Corp. (+1913% as of June/19/09) ( Link to article )
7. TerreStar Corporation (+44% as of July/9/09) ( Link to article )
8. Hard to Treat Diseases, Inc. (+1045% as of July/21/09) ( Link to article )
9. Somaxon Pharmaceuticals, Inc. (+67.26% as of July/22/09) ( Link to article )
10. SymPowerco Corp. (+157.14% as of July/29/09) ( Link to article )
Recent news on our latest pick, (PINK:SYMW)
Tom Bustamante, the Managing Partner of Ludlow Capital Research commented, “With the recent announcement of Chevy’s electric Volt the demand for alternative electric vehicles has been gaining strong interest. On the small cap side, SymPowerco’s subsidiaries, HOSS Motor Sports and Highline Hydrogen Hybrids Systems, should offer operating holding corps for joint ventures and development of electric motor car solutions.”
“The stock is considered highly speculative, but seems to be attracting increasing attention from the market. Technically the stock has been generating increasing strong retail volume, and looks to be making an attempt to move above their longer-term trend line moving average. Again, it may be a very small speculative micro-cap play, but on mere momentum we wouldn’t be surprised to see this company push up above the $0.01 mark in the very near-term.”
Technical Analysis
According to StockTA.com, short, medium, and long term indicators display the largest level of BUY RATING near the 100% level. Resistance is set to 0.0025 which should be tested within the coming days. Any new company PRs regarding the acquisition process of the new subsidiaries, and or an update on the facility in Dumas, Arkinsas, and you can expect the price per share to easily surpass the 0.0030 level.
